PT-141 Research Peptide | Bremelanotide Cyclic Peptide

Description

PT-141 Research Peptide | Bremelanotide Cyclic Peptide

 

PT-141 Research Peptide is a synthetic cyclic heptapeptide featuring a defined amino-acid sequence and a cyclic peptide structure. It is also associated with the research name bremelanotide. The reported molecular formula is C₅₀H₆₈N₁₄O₁₀, with a molecular weight of approximately 1,025.2 g/mol.

At LV Longevity Peptides, PT-141 is positioned as a specialized research material for controlled laboratory and analytical applications involving cyclic peptide structure, molecular interactions, stability, and peptide behavior under defined experimental conditions.

This product version is supplied as a pre-formulated aqueous research solution, rather than a conventional lyophilized powder. Because it is a finished liquid formulation, the product page should emphasize compound identity, labeled content, formulation volume, and batch-specific assay information.

PT-141 Research Peptide Sequence

The reported PT-141 sequence is:

Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH

The notation indicates an N-acetylated cyclic peptide containing a norleucine residue and a defined cyclic structure. The cyclic configuration is an important part of PT-141’s chemical identity and should be retained in technical product documentation.

141 Research Applications

PT-141 may be investigated in controlled laboratory environments for:

• Cyclic peptide structure and sequence characterization

• Peptide–receptor interaction studies

• Melanocortin-related biochemical research

• Molecular signaling pathway analysis

• Structure–activity relationship investigations

• Peptide stability and degradation studies

• Analytical method development

• Comparative research involving synthetic cyclic peptides

These descriptions refer to non-clinical laboratory research only and should not be interpreted as claims of medical efficacy or consumer use.

PT-141 and Bremelanotide

PT-141 is commonly associated with bremelanotide, a synthetic cyclic peptide compound. However, an LV research material should not be represented as an approved pharmaceutical product or as a substitute for any prescription medication.

The LV product page should clearly distinguish the research compound from regulated pharmaceutical products and should maintain a strict research-use-only position.

Technical Specifications

 

Chemical Information:

• Chemical Name: PT-141
• Molecular Formula: C₅₀H₆₈N₁₄O₁₀
• Molecular Weight: 1025.2 g/mol
• Sequence: Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-OH

Molecular Structure: